UK/US - Biotechnology firm Sygen is abandoning its legal action against Watson Wyatt over "inappropriate" advice on setting up the firm's pension scheme.
The US-based firm’s decision will come as great relief to the consultant which could have triggered similar claims in the UK. Sygen set up its scheme after the firm split from previous owner Dal...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date